Source: Ceese Bulletin nr. 21 - May 2024
Despite economic crisis, Cuban scientists continue to surprise us. Our British colleagues announce that UC London School of Pharmacy and Cuba’s leading research centre C-NEURO will start pre-clinical trials with the promising Alzheimer therapeutic CNEURO-201, a molecule that disagregates amloïde plaques (proteïnes that pile up in brain) and prevents to stick amyloïds together.
Another product,Heberferon, has proved safe and effective in treating highrisk skin cancer in Cuba but needs clinical trials in other countries to bring it on the market there. Our British friends of CRICKET CIC succeeded to arrange that in the UK https://www.cricketcic.net/ Perhaps a good idea for other european universities to partner with BioCubaFarma to bring another of their innovative products to Europe https://www.nature.com/articles/d43747-020-00522-5 Characteristic for the atmosphere under scientists, here a quote of my friend Julio Cesar Aguilar from CIGB: “There are two options: to fight or surrender. As always, Cubans are no people of second options ”.